Concomitant Administration of a New Hexavalent Vaccine With a Meningococcal Serogroup C Conjugate Vaccine in Healthy Infants During Primary Series Immunisation Followed by Booster Vaccination
Clinical trial NCT01839175 · COMPLETED
Trial details
- NCT number
- NCT01839175
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-01
- Primary completion
- 2014-07-01
- Enrollment
- 350
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.